| 1 |
NCT04130867 |
Recruiting
New |
Rehabilitation Manometry Study |
|
- Procedure: pHRM
- Procedure: VFSS
|
Observational
|
|
- University of Wisconsin, Madison
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Change in pHRM from Baseline
- Change in Sydney Swallowing Questionnaire between timepoints
- Change in Eat Assessment Tool Score between timepoints
- (and 3 more...)
|
300 |
All |
18 Years to 99 Years (Adult, Older Adult) |
NCT04130867 |
2019-0576
A539770
SMPH/SURGERY/SURGERY*OT |
|
November 2019 |
November 2023 |
November 2023 |
October 18, 2019 |
October 18, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 2 |
NCT04125758 |
Recruiting
New |
Stress-physiology Coherence, Interoception, and Well-being Following Mindfulness Training or Tracking Time Spent on Mobile Device |
- Not Seeking to Treat Any Conditions
|
- Behavioral: Mindfulness training
- Behavioral: Tracking time spent on mobile device
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
- Mind and Life Institute, Hadley, Massachusetts
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Investigator, Outcomes Assessor)
- Primary Purpose: Basic Science
|
- Change in subjective stress-heart rate coherence
|
260 |
All |
18 Years to 65 Years (Adult, Older Adult) |
NCT04125758 |
2019-0153 |
SCIM |
October 14, 2019 |
January 15, 2021 |
January 15, 2021 |
October 14, 2019 |
October 14, 2019 |
|
- University of Wisconsin - Madison
Madison, Wisconsin, United States
|
|
| 3 |
NCT04117438 |
Active, not recruiting
New |
Tell us Your Food Story |
|
|
Observational
|
|
- Medical College of Wisconsin
|
Other |
- Observational Model: Case-Crossover
- Time Perspective: Cross-Sectional
|
- Breast cancer patients relationship with food.
|
50 |
Female |
Child, Adult, Older Adult |
NCT04117438 |
PRO00034502 |
|
October 1, 2019 |
November 2020 |
November 2020 |
October 7, 2019 |
October 7, 2019 |
|
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 4 |
NCT04113798 |
Recruiting
New |
Exercise and Therapeutic Learning Among Women With PTSD |
|
- Other: Day 1 Assessments
- Other: Day 2 Fear Learning
- Other: Day 3 Fear Extinction
- (and 3 more...)
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Participant Skin Conductance Responding (SCR)
- Group Differences in Serum Brain-Derived Neurotrophic Factor (BDNF)
- Group Differences in Serum Endocannabinoid (eCB) Content
- (and 3 more...)
|
30 |
Female |
21 Years to 50 Years (Adult) |
NCT04113798 |
2018-0845
A538900
SMPH/PSYCHIATRY/PSYCHIATRY |
|
April 8, 2019 |
June 2020 |
June 2020 |
October 3, 2019 |
October 3, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 5 |
NCT04112446 |
Recruiting
New |
Study to Evaluate Absorption, Metabolism and Excretion of Single-dose [14C]-Saroglitazar in Healthy Male Subjects |
|
- Drug: Saroglitazar magnesium
|
Interventional
|
Phase 1 |
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- AUC from time zero to infinity (AUC0-∞)
- AUC from time zero to the last quantifiable concentration (AUC0-t) administration of [14C]-saroglitazar magnesium
- Cmax
- (and 12 more...)
|
8 |
Male |
18 Years to 55 Years (Adult) |
NCT04112446 |
SARO.19.002 |
|
September 20, 2019 |
October 28, 2019 |
October 28, 2019 |
October 2, 2019 |
October 2, 2019 |
|
- Covance Clinical Research Unit Inc.
Madison, Wisconsin, United States
|
|
| 6 |
NCT04105543 |
Not yet recruiting
New |
CLR 131 Combined With Radiation for Head and Neck Cancer |
|
|
Interventional
|
Phase 1 |
- University of Wisconsin, Madison
- National Institute of Dental and Craniofacial Research (NIDCR)
- Cellectar Biosciences, Inc.
|
Other / NIH / Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Incidence of Adverse Events
- CLR 131 Tumor Uptake via SPECT/CT Imaging
- Median Radiation Treatment Time
- (and 5 more...)
|
24 |
All |
18 Years and older (Adult, Older Adult) |
NCT04105543 |
UW19041
P50DE026787
2019-0681
17-030-E
A534260
SMPH/MEDICINE/MEDICINE*H |
|
October 2019 |
January 2022 |
January 2022 |
September 26, 2019 |
September 26, 2019 |
|
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
|
|
| 7 |
NCT04103541 |
Completed
New |
Epigenetic Impact of a Psychotherapeutic Program in Adolescents With Severe Adverse Experiences |
- Children Exposed to Adverse Experiences
|
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Investigator)
- Primary Purpose: Treatment
|
- Change in the level of DNA methylation following IEP-Colombia psychotheraupeutic program
- Change in Short PTSD Rating Interview (SPRINT) score following IEP-Colombia psychotheraupeutic program
- Change in Mindful Attention and Awareness Scale for Adolescents (MAAS-A) score following IEP-Colombia psychotheraupeutic program
|
44 |
All |
13 Years to 18 Years (Child, Adult) |
NCT04103541 |
2019-0189
Psychology, |
|
June 1, 2019 |
July 1, 2019 |
July 1, 2019 |
September 25, 2019 |
September 26, 2019 |
|
- University of Wisconsin Madison
Madison, Wisconsin, United States
|
|
| 8 |
NCT04100577 |
Recruiting
New |
Today Not Tomorrow Pregnancy and Infant Support Program (TNT- PISP) |
- Infant Mortality
- Infant Death
- Racial Bias
- (and 14 more...)
|
- Other: Today Not Tomorrrow Pregnancy and Infant Support Program
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
- Wisconsin Partnership Program
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Participant recruitment as assessed by percentage of participants enrolled in Today Not Tomorrow Pregnancy and Infant Support Program (TNT-PISP)
- Retention rate of participants as assessed by percentage of participants adhered to study for 2 years
- Preliminary Maternal Child Health Outcomes: Birth weight
- (and 4 more...)
|
40 |
Female |
18 Years to 99 Years (Adult, Older Adult) |
NCT04100577 |
2019-0684 |
|
October 3, 2019 |
August 31, 2021 |
August 31, 2021 |
September 24, 2019 |
October 7, 2019 |
|
- University of Wisconsin Madison
Madison, Wisconsin, United States
|
|
| 9 |
NCT04099537 |
Recruiting
New |
Skin Picking Approach Avoidance Task |
|
- Behavioral: Computerized cognitive training
|
Interventional
|
Not Applicable |
- University of Wisconsin, Milwaukee
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Changes in Behavioral Approach Tendency After a Single Training Session
- Changes in Urges to Pick After Training
- Changes in scores on the Skin Picking Scale-Revised (SPS-R).
|
60 |
All |
18 Years to 60 Years (Adult) |
NCT04099537 |
SPAAT2018 |
SPAAT |
July 2, 2018 |
December 2, 2020 |
December 2, 2020 |
September 23, 2019 |
September 23, 2019 |
|
- Psychology Clinic, University of Wisconsin-Milwaukee
Milwaukee, Wisconsin, United States
|
|
| 10 |
NCT04095975 |
Enrolling by invitation |
Effectiveness of Urinary Alkalinizing Agents on Kidney Stone Risk |
|
- Dietary Supplement: Baking Soda
- Dietary Supplement: LithoLyte
- Drug: Urocit K
|
Interventional
|
Phase 4 |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change in 24 hour urine citrate
- Change in 24 hour urine pH
- Post-intervention 24-hour urine calcium
- (and 5 more...)
|
90 |
All |
18 Years and older (Adult, Older Adult) |
NCT04095975 |
2019-0621
A539800
SMPH/UROLOGY/UROLOGY |
|
August 28, 2019 |
August 2021 |
August 2021 |
September 19, 2019 |
September 19, 2019 |
|
- UW-Madison
Madison, Wisconsin, United States
|
|
| 11 |
NCT04095091 |
Recruiting |
Real-time Tumor Localization and Guidance for Radiotherapy Using Ultrasound (US) and Magnetic Resonance (MR) |
|
- Device: 4D Planar US Transducer
|
Observational
|
|
- University of Wisconsin, Madison
- National Institutes of Health (NIH)
|
Other / NIH |
- Observational Model: Other
- Time Perspective: Prospective
|
- Feasibility testing
- MR/US Motion Management Platform
- Accuracy of image-guidance technique
- Test/re-test
|
40 |
All |
18 Years and older (Adult, Older Adult) |
NCT04095091 |
2017-0684 |
|
September 14, 2017 |
June 30, 2020 |
June 30, 2021 |
September 19, 2019 |
September 19, 2019 |
|
- University of Wisconsin, Madison
Madison, Wisconsin, United States
|
|
| 12 |
NCT04093401 |
Recruiting |
The VIDYA Study-designed to Determine if Patients With a History of Basal Cell Carcinoma Are More Inclined to Return for Follow-up if Their Risk of a Subsequent Basal Cell Carcinoma is Quantitated. |
|
- Other: individualized risk assessment
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Supportive Care
|
- Number of participants who have a followup second skin exam by a dermatologist within 1 year of diagnosis of their first basal cell carcinoma (BCC)
- Frequency of sunscreen use when out in sun
- Frequency of sunburns within the past year
|
94 |
All |
18 Years and older (Adult, Older Adult) |
NCT04093401 |
UW19002
2019-0077
A534300
SMPH/DERMATOLOGY/DERMATOLOG |
|
October 2019 |
October 2020 |
October 2020 |
September 18, 2019 |
September 25, 2019 |
|
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
|
|
| 13 |
NCT04090866 |
Recruiting |
Cardiac Metabolic Remodeling After Pulmonary Vasodilator Therapy in Pulmonary Arterial Hypertension: A Pilot Study |
- Pulmonary Arterial Hypertension
- Right-Sided Heart Failure
|
|
Observational
|
|
- University of Wisconsin, Madison
- United Therapeutics
|
Other / Industry |
- Observational Model: Other
- Time Perspective: Prospective
|
- Ability to augment glucose uptake ("substrate flexibility"), defined as change in rate of glucose uptake from rest to exercise
- Change in substrate flexibility after initiation of pulmonary vasodilator therapy
|
10 |
All |
18 Years to 75 Years (Adult, Older Adult) |
NCT04090866 |
2019-0286
A534285
SMPH/MEDICINE/MEDICINE*P |
|
October 2019 |
March 2022 |
March 2022 |
September 16, 2019 |
October 7, 2019 |
|
- University of Wisconsin-Madison
Madison, Wisconsin, United States
|
|
| 14 |
NCT04089332 |
Recruiting |
Insulin Resistance in Adolescents |
|
- Other: Oral Glucose Tolerance Test
- Device: 3 Tesla MRI
- Device: Intravenous Catheter
- Other: Cognitive Tests
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
Other / NIH |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- Cognitive Function as determined by WASI (Verbal IQ)
- Cognitive Function as determined by WASI (Performance IQ)
- Cognitive Function as determined by NIH Toolbox (List Learning) Test
- (and 10 more...)
|
55 |
All |
12 Years to 18 Years (Child, Adult) |
NCT04089332 |
2019-0361
1R21HD097510-01A1
A176000
EDUC/KINESIOLOGY/KINESIOLOG
19PRE34450141 |
|
October 4, 2019 |
July 31, 2021 |
July 31, 2021 |
September 13, 2019 |
October 10, 2019 |
|
- University of Wisconsin-Madison
Madison, Wisconsin, United States
|
|
| 15 |
NCT04081662 |
Recruiting |
Examining the Efficacy of Acceptance and Commitment Therapy (ACT) Microinterventions for Distressed First-Generation College Students |
- Psychological Distress
- Self-Assessment
- Mood Change
|
- Behavioral: compACT Intervention
|
Interventional
|
Phase 1 |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Feasibility of the ACT micro-intervention: percentage adherence to PHQ-2, PSS-4, and activity prompts
- Safety of ACT micro-intervention: Change in Patient Health Questionnaire 9 (PHQ-9)
- Effectiveness of the ACT micro-intervention: proximal changes in mood outcomes as a result of intervention as indicated by self-reported activity of participant
- (and 2 more...)
|
50 |
All |
18 Years to 19 Years (Adult) |
NCT04081662 |
2019-0819
Biostat & Med |
CompACT |
October 2019 |
September 2021 |
September 2021 |
September 9, 2019 |
October 8, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 16 |
NCT04075097 |
Recruiting |
Pain, Psychological, and Endocannabinoid Responses to Yoga in Breast Cancer Survivors With Chemotherapy-induced Neuropathic Pain |
- Breast Cancer
- Chemotherapy-induced Peripheral Neuropathy
- Neuropathic Pain
|
- Behavioral: Aerobic exercise
- Behavioral: Iyengar yoga
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
- American College of Sports Medicine
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Other
|
- Change in Neuropathic Pain Sensations as determined by VAS
- Change in cold pain threshold
- Change in total mood disturbance (Profile of Mood States)
- Change in plasma concentration of 2-Arachidonoylglycerol (2-AG)
|
12 |
Female |
18 Years and older (Adult, Older Adult) |
NCT04075097 |
2018-1518
A176000
EDUC/KINESIOLOGY/KINESIOLOG
UW18057 |
|
July 31, 2019 |
December 2019 |
December 2019 |
August 30, 2019 |
October 9, 2019 |
|
- University of Wisconsin-Madison Natatorium
Madison, Wisconsin, United States
|
|
| 17 |
NCT04061720 |
Not yet recruiting |
Identifying Effective Treatment for Veterans Unwilling to Quit Smoking |
- Tobacco Dependence
- Veterans
|
- Behavioral: Enhanced Chronic Care
- Behavioral: Standard Care
|
Interventional
|
Not Applicable |
- VA Office of Research and Development
- University of Wisconsin, Madison
|
U.S. Fed / Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Investigator)
- Primary Purpose: Treatment
|
- 7-Day Point-Prevalence Abstinence
- Use of cessation treatment
|
500 |
All |
18 Years and older (Adult, Older Adult) |
NCT04061720 |
NURA-009-18F |
|
November 1, 2019 |
September 30, 2024 |
September 30, 2024 |
August 20, 2019 |
August 20, 2019 |
|
- William S. Middleton Memorial Veterans Hospital, Madison, WI
Madison, Wisconsin, United States
|
|
| 18 |
NCT04059354 |
Recruiting |
Down Syndrome Speech Intelligibility Diagnostic Treatment Study |
|
- Behavioral: Speech therapy addressing phonology and motor learning
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
- Office of the Vice Chancellor for Research and Graduate Education
- Wisconsin Alumni Research Foundation
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change in formant frequency for vowels in recorded words/sentences.
- Change in formant bandwidth for vowels in recorded words/sentences.
- Change in time to produce the individual phonemes in recorded words/sentences will be measured.
- (and 7 more...)
|
10 |
Male |
7 Years to 16 Years (Child) |
NCT04059354 |
2019-0706 |
|
August 30, 2019 |
July 31, 2020 |
August 1, 2020 |
August 16, 2019 |
September 4, 2019 |
|
- Waisman Center
Madison, Wisconsin, United States
|
|
| 19 |
NCT04057742 |
Recruiting |
AlloSure for the Monitoring of Antibody Mediated Processes After Kidney Transplantation |
- Kidney Transplant Failure and Rejection
|
- Diagnostic Test: AlloSure ddcfDNA assay
- Diagnostic Test: AlloMap assay
- Diagnostic Test: Inflammatory Cytokines
|
Observational
|
|
- University of Wisconsin, Madison
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- CareDx
|
Other / NIH / Industry |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Incidence of Biopsy Confirmed AMR
- Banff Pathology
- Renal Allograft Function: Concentration of Serum Creatinine (sCr)
- (and 2 more...)
|
100 |
All |
18 Years to 75 Years (Adult, Older Adult) |
NCT04057742 |
2019-0750
1K23DK122136-01
A534280
SMPH/MEDICINE/MEDICINE*N |
All-MAP |
October 4, 2019 |
October 1, 2022 |
October 1, 2022 |
August 15, 2019 |
October 7, 2019 |
|
- University of Wisconsin - Madison
Madison, Wisconsin, United States
|
|
| 20 |
NCT04050683 |
Enrolling by invitation |
Evaluation of Hemodynamic Parameters Following Transjugular Intrahepatic Portosystemic Shunt (TIPS) |
|
- Procedure: Study - Transjugular Intrahepatic Portosystemic Shunt (TIPS)
- Procedure: Control - Transjugular Intrahepatic Portosystemic Shunt (TIPS)
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
- Radiological Society of North America
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Diagnostic
|
- Cardiac related events
- Clinical success
- Overall survival
- (and 2 more...)
|
24 |
All |
18 Years and older (Adult, Older Adult) |
NCT04050683 |
PRO 35079 |
|
September 25, 2019 |
December 2024 |
December 2024 |
August 8, 2019 |
September 27, 2019 |
|
- Medical College of Wisconsin/Froedtert Hospital
Milwaukee, Wisconsin, United States
|
|
| 21 |
NCT04049383 |
Not yet recruiting |
CAR-20/19-T Cells in Pediatric Patients With Relapsed/Refractory B Cell ALL |
- Acute Lymphoblastic Leukemia, in Relapse
- Acute Lymphoblastic Leukemia With Failed Remission
- Acute Lymphoblastic Leukemia Recurrent
- (and 3 more...)
|
- Biological: CAR-20/19-T cells
|
Interventional
|
Phase 1 |
- Medical College of Wisconsin
- Children's Hospital and Health System Foundation, Wisconsin
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Sequential Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Determine the safety (dose level) of CAR-20/19-T cell administration in relapsed refractory B-ALL.
- Determine the feasibility to manufacture CAR-20/19-T cells locally from pediatric and young adult apheresis products using the CliniMACS Prodigy Cell processing device.
- Determine the anti-tumor responses as measured by response rates.
- (and 4 more...)
|
24 |
All |
1 Year to 39 Years (Child, Adult) |
NCT04049383 |
CAR-20/19-T |
CAR-20/19-T |
October 1, 2019 |
October 1, 2022 |
February 1, 2023 |
August 8, 2019 |
August 26, 2019 |
|
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 22 |
NCT04048863 |
Not yet recruiting |
Effect of B. Braun Peripheral Advantage Program on Complications, Indwell Time and First Stick Success of PIVC Therapy |
- Complications Associated With Device
|
- Device: B. Braun Peripheral Advantage (PA) Program
- Device: Hospital Standard of Care
|
Interventional
|
Not Applicable |
|
Industry |
- Allocation: Non-Randomized
- Intervention Model: Sequential Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Incidence of complications associated with PIVC use
- Catheter indwell time
- First attempt success rates (first stick success)
- Aggregate costs associated with catheter insertion
|
632 |
All |
18 Years and older (Adult, Older Adult) |
NCT04048863 |
US-N-H-1801 |
|
November 30, 2019 |
November 30, 2020 |
November 30, 2020 |
August 7, 2019 |
August 7, 2019 |
|
- Mayo Clinic
La Crosse, Wisconsin, United States
|
|
| 23 |
NCT04040205 |
Recruiting |
Abemaciclib for Treatment of Advanced Bone and Soft Tissue Sarcoma Identified as Having CDK Pathway Alteration |
- Chondrosarcoma
- Osteosarcoma
- Soft Tissue Sarcoma
|
|
Interventional
|
Phase 2 |
- Medical College of Wisconsin
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Progression-free survival
- Death
|
45 |
All |
18 Years and older (Adult, Older Adult) |
NCT04040205 |
PRO34388 |
|
October 7, 2019 |
September 1, 2023 |
September 1, 2024 |
July 31, 2019 |
October 9, 2019 |
|
- Froedtert Hospital & the Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 24 |
NCT04039399 |
Recruiting |
Ischemic Conditioning Chronic Stroke Study |
|
- Procedure: Ischemic Conditioning
- Procedure: Sham Ischemic Conditioning
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Double (Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in Plasma Norepinephrine Concentration
- Change in Plasma Epinephrine Concentration
- Change in Systolic Blood Pressure
|
15 |
All |
18 Years to 85 Years (Adult, Older Adult) |
NCT04039399 |
PRO00033275 |
|
July 1, 2019 |
June 30, 2020 |
December 31, 2020 |
July 31, 2019 |
July 31, 2019 |
|
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 25 |
NCT04036058 |
Not yet recruiting |
Effect of Expanding (Gloving) Barrier Precautions for Reducing Clostridium Difficile Acquisition (and Infection) in VA |
|
|
Interventional
|
Not Applicable |
- VA Office of Research and Development
|
U.S. Fed |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Health Services Research
|
- C. difficile acquisition rates
- Hospital-onset C. difficile infection (HO-CDI) rates
- CLABSI (HAI) rates
- (and 7 more...)
|
10 |
All |
18 Years and older (Adult, Older Adult) |
NCT04036058 |
IIR 18-087 |
GLORI |
January 1, 2020 |
December 31, 2022 |
December 31, 2022 |
July 29, 2019 |
July 29, 2019 |
|
- William S. Middleton Memorial Veterans Hospital, Madison, WI
Madison, Wisconsin, United States
|
|
| 26 |
NCT04033341 |
Recruiting |
A Study of LY3214996 in Healthy Participants |
|
- Drug: LY3214996
- Drug: [14C]-LY3214996
|
Interventional
|
Phase 1 |
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- Urinary Excretion of LY3214996 Radioactivity Over Time Expressed As A Percentage of the Total Radioactive Dose Administered
- Fecal Excretion of LY3214996 Radioactivity Over Time Expressed As A Percentage of the Total Radioactive Dose Administered
- Pharmacokinetics (PK): Maximum Concentration (Cmax) of LY3214996
- (and 2 more...)
|
8 |
Male |
18 Years to 65 Years (Adult, Older Adult) |
NCT04033341 |
17199
I8S-MC-JUAD |
|
August 1, 2019 |
October 28, 2019 |
October 28, 2019 |
July 26, 2019 |
August 20, 2019 |
|
- Covance Clinical Research Inc
Madison, Wisconsin, United States
|
|
| 27 |
NCT04029961 |
Recruiting |
A Virtual Reality-based Radiation Therapy Education Program |
- Anxiety
- Stress
- Satisfaction, Patient
- (and 2 more...)
|
- Other: Video Education
- Other: VR-based Education
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
- Marquette University
- Froedtert Hospital
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Other
|
- Mean difference in pre-post changes between study arms in State Trait Anxiety Inventory (STAI) for Adults scores.
- Mean difference in pre-post changes between study arms in Visual Analog Scale for Stress scores
- Mean difference in pre-post changes between study arms in Visual Analog Scale for Preparedness scores
- (and 3 more...)
|
36 |
Female |
18 Years and older (Adult, Older Adult) |
NCT04029961 |
PRO00032593 |
|
August 12, 2019 |
October 2019 |
October 2019 |
July 23, 2019 |
September 6, 2019 |
|
- Froedtert Hospital and Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 28 |
NCT04028700 |
Not yet recruiting |
The Impact of Oxidative Stress on Erythrocyte Bilogy |
- Sickle Cell Disease Without Crisis
|
- Biological: Red Blood Cell Transfusion
|
Interventional
|
Phase 2 |
- Blood Center of Wisconsin
- Columbia University
- Medical College of Wisconsin
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Single (Participant)
- Primary Purpose: Supportive Care
|
- Post-Transfusion Recovery
- Hemoglobin A
|
16 |
All |
18 Years to 60 Years (Adult) |
NCT04028700 |
PRO00035124 |
RBC Survival |
October 1, 2019 |
October 1, 2023 |
October 1, 2023 |
July 23, 2019 |
July 23, 2019 |
|
- Medical College of Wisconsin and Froedtert Hospital
Milwaukee, Wisconsin, United States
|
|
| 29 |
NCT04028076 |
Recruiting |
Improving Diabetes Medication Adherence for African Americans in Madison and Milwaukee Through Peer Support |
- Type2 Diabetes
- Medication Adherence
- Medication Nonadherence
- Peer Support
|
- Behavioral: Peers Supporting Health-Literacy, Self Efficacy, Advocacy and Adherence
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Health Services Research
|
- Change in Hemoglobin A1c
- Beliefs about Medicines Questionnaire
- Culturally adapted illness perception questionnaire
- (and 3 more...)
|
30 |
All |
30 Years to 65 Years (Adult, Older Adult) |
NCT04028076 |
2019-0721 |
|
July 10, 2019 |
July 2020 |
October 2020 |
July 22, 2019 |
September 24, 2019 |
|
- University of Wisconsin - Madison
Madison, Wisconsin, United States
|
|
| 30 |
NCT04026373 |
Completed |
RAC Pilot - The Feasibility and Effectiveness of a Brief Preventive Intervention Following Psychological Trauma |
- Stress Disorders, Post-Traumatic
|
- Behavioral: modified Prolonged Exposure
- Behavioral: Treatment as usual
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Clinician-Administered PTSD Scale
|
74 |
All |
18 Years to 75 Years (Adult, Older Adult) |
NCT04026373 |
PRO00024745 |
|
March 8, 2016 |
October 17, 2018 |
October 17, 2018 |
July 19, 2019 |
July 19, 2019 |
|
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 31 |
NCT04023877 |
Active, not recruiting |
A Study to Determine the Metabolism and Elimination of [14C]E2027 in Healthy Male Participants |
- Dementias With Lewy Bodies
|
|
Interventional
|
Phase 1 |
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Cumulative Percent of the Radiolabeled Dose of [14C]E2027 in Biological Matrices (Blood, Urine, Feces and Toilet Tissue)
- Maximum Concentration (Cmax) of Radiolabeled [14C]E2027, Non-Radiolabeled E2027 and Metabolites in Biological Matrices
- Time to Reach Maximum (Peak) Concentration (Tmax) of Radiolabeled [14C]E2027, Non-Radiolabeled E2027 and Metabolites in Biological Matrices
- (and 12 more...)
|
8 |
Male |
18 Years to 55 Years (Adult) |
NCT04023877 |
E2027-A001-005 |
|
July 18, 2019 |
August 26, 2019 |
October 11, 2019 |
July 18, 2019 |
October 16, 2019 |
|
- Covance Clinical Research Unit Inc.
Madison, Wisconsin, United States
|
|
| 32 |
NCT04020276 |
Suspended |
OAR-Based, Dose Escalated SBRT With Real Time Adaptive MRI Guidance for Liver Metastases |
- Liver Metastases
- Stereotactic Body Radiation Therapy
- MRI-guided Treatment
|
|
Interventional
|
Phase 1 |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Number of Participants with Acute Dose Limiting Toxicity (DLT)
- Progression Free Survival (PFS)
- Overall Survival (OS)
- Local Control Rates
|
48 |
All |
18 Years and older (Adult, Older Adult) |
NCT04020276 |
UW18110
SMPH/HUMAN ONCOLOGY/HUMAN ONCO
A533300
2019-0373 |
|
November 1, 2019 |
August 1, 2023 |
August 1, 2023 |
July 16, 2019 |
October 8, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 33 |
NCT04020211 |
Recruiting |
HF10 Treatment of Chronic Knee Pain |
- Chronic Pain Post-Procedural
|
- Device: Senza HF10 Therapy
|
Observational
|
|
|
Industry |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Responders and Improvement in Oxford Knee Score (OKS)
- Change in Disability and Functioning
- Change in Functioning
- (and 8 more...)
|
75 |
All |
18 Years and older (Adult, Older Adult) |
NCT04020211 |
CA2018-5 US CPSP-3 |
CPSP-3 |
March 14, 2019 |
February 2021 |
March 2022 |
July 15, 2019 |
July 15, 2019 |
|
- Pain Management
Greenfield, Wisconsin, United States
|
|
| 34 |
NCT04018495 |
Recruiting |
STeP IT UP CF: STimulating ImProved Health And Well-being In CysTic Fibrosis |
|
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
- Cystic Fibrosis Foundation
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Participants will Consistently Use Fitbit Tracker
- Integration Tool Development
|
21 |
All |
18 Years to 100 Years (Adult, Older Adult) |
NCT04018495 |
34812 |
|
September 10, 2019 |
May 2021 |
May 2022 |
July 12, 2019 |
September 23, 2019 |
|
- Medical College of Wisconsin/Froedtert Hospital
Milwaukee, Wisconsin, United States
|
|
| 35 |
NCT04014374 |
Active, not recruiting |
Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab |
|
|
Observational
|
|
- Kyowa Kirin Pharmaceutical Development, Inc.
|
Industry |
- Observational Model: Cohort
- Time Perspective: Other
|
- Assess toxicities or complications of transplant among patients who were treated with mogamulizumab, alone or in combination
|
50 |
All |
18 Years and older (Adult, Older Adult) |
NCT04014374 |
SC18-09 |
|
September 10, 2019 |
February 2024 |
February 2024 |
July 10, 2019 |
October 11, 2019 |
|
- CIBMTR
Milwaukee, Wisconsin, United States
|
|
| 36 |
NCT04011644 |
Not yet recruiting |
Mobile Health for Alcohol Use Disorders in Clinical Practice |
- Alcohol Drinking
- Telemedicine
|
- Behavioral: A-CHESS self-monitored
- Behavioral: A-CHESS peer-supported
- Behavioral: A-CHESS clinically-integrated
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Number of risky drinking days
- Number of patients who are willing to share data
- Number of healthcare services used in the past 6 months
- (and 15 more...)
|
546 |
All |
18 Years to 100 Years (Adult, Older Adult) |
NCT04011644 |
2019-0337
R01AA024150 |
|
November 2019 |
August 2022 |
April 2023 |
July 8, 2019 |
October 3, 2019 |
|
- UW Health at the American Center
Madison, Wisconsin, United States
|
|
| 37 |
NCT04007081 |
Recruiting |
Salivary Gland Autotransplantation for Treatment of XRT Induced Xerostomia |
- Xerostomia
- Head and Neck Cancer
|
- Procedure: Bone Marrow Aspiration
- Diagnostic Test: Ultrasound Imaging of Salivary Glands
- Other: Salivary Assay
- Other: Quality of Life Instruments
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- Number of Participant's whose Marrow-Derived MSCs Can be Expanded in vitro to > 50 million cells within two weeks
- Change in participant QoL: XeQOL
- Change in participant QoL: MDADI
- (and 4 more...)
|
15 |
All |
18 Years and older (Adult, Older Adult) |
NCT04007081 |
UW19009
2019-0497
SMPH/HUMAN ONCOLOGY/HUMAN ONCO |
|
October 2019 |
January 31, 2021 |
January 31, 2021 |
July 3, 2019 |
September 6, 2019 |
|
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
|
|
| 38 |
NCT03998423 |
Recruiting |
Oral Fecal Microbiota Transplant Feasibility Study in Alzheimer's Disease |
|
- Biological: Fecal Microbiota Transplant
|
Interventional
|
Phase 1 |
- University of Wisconsin, Madison
- Wisconsin Partnership Program
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Safety: Proportion of participants with treatment-related adverse events, serious adverse events, or adverse events of special interest.
- Feasibility: Participant recruitment rate
- Feasibility: Eligibility
- (and 20 more...)
|
30 |
All |
45 Years and older (Adult, Older Adult) |
NCT03998423 |
AMBITION
2018-0283 |
AMBITION |
October 2019 |
May 31, 2022 |
May 31, 2022 |
June 26, 2019 |
October 8, 2019 |
|
- University of Wisconsin - Madison
Madison, Wisconsin, United States
|
|
| 39 |
NCT03997448 |
Recruiting |
Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149 |
- Gastroesophageal Cancer
- Adenocarcinoma
|
- Drug: Pembrolizumab
- Drug: Abemaciclib
|
Interventional
|
Phase 2 |
- Nataliya Uboha
- Eli Lilly and Company
- Big Ten Cancer Research Consortium
|
Other / Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Progression-Free Survival
- Progression-Free Survival Rate at 6 Months
- Disease Control Rate
- (and 3 more...)
|
34 |
All |
18 Years and older (Adult, Older Adult) |
NCT03997448 |
BTCRC-GI18-149 |
|
August 26, 2019 |
August 2021 |
August 2022 |
June 25, 2019 |
September 17, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 40 |
NCT03988205 |
Recruiting |
Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia |
|
- Behavioral: Outpatient Care Model
- Drug: CPX-351
|
Interventional
|
Phase 4 |
- Medical College of Wisconsin
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Adherence to Recommendations
- Adherence to Readmission Recommendations
|
120 |
All |
18 Years and older (Adult, Older Adult) |
NCT03988205 |
PRO34597 |
|
August 28, 2019 |
December 1, 2021 |
December 1, 2022 |
June 17, 2019 |
October 18, 2019 |
|
- Froedtert Hospital
Milwaukee, Wisconsin, United States
|
|
| 41 |
NCT03981887 |
Completed |
Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Intravenous Nafithromycin |
|
- Drug: Nafithromycin
- Other: Placebo
|
Interventional
|
Phase 1 |
- Wockhardt
- Clinartis, LLC
- Keystone Bioanalytical, Inc.
|
Industry / Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Basic Science
|
- To assess safety
- To assess multiple dose drug tolerability
- To assess plasma PK parameters profile
|
10 |
All |
18 Years to 55 Years (Adult) |
NCT03981887 |
W-4873-105 |
|
June 18, 2019 |
July 2, 2019 |
August 7, 2019 |
June 11, 2019 |
October 2, 2019 |
|
- Spaulding Clinical Research
West Bend, Wisconsin, United States
|
|
| 42 |
NCT03980067 |
Recruiting |
Impact of Pre-Sedation Virtual Reality Game on Post-Discharge Negative Behaviors in the Pediatric Emergency Department |
|
- Other: Virtual Reality Game
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Supportive Care
|
- Post-Hospitalization Behavior Questionnaire (PHBQ)
- Modified Yale Preoperative Anxiety Scale (m-YPAS)
|
243 |
All |
6 Years to 17 Years (Child) |
NCT03980067 |
1300058-5 |
|
May 17, 2019 |
May 17, 2021 |
May 17, 2021 |
June 10, 2019 |
June 19, 2019 |
|
- Children's Hospital of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 43 |
NCT03978455 |
Recruiting |
A Pilot Study of the Learn, Connect, and Quit Mobile Application |
|
- Behavioral: Learn, Connect, and Quit Mobile Application
|
Observational
|
|
- University of Wisconsin, Madison
- National Cancer Institute (NCI)
- University of Wisconsin Center for Tobacco Research and Intervention
|
Other / NIH |
- Observational Model: Case-Only
- Time Perspective: Prospective
|
- Total time spent watching videos
- Clinical Utility of the Learn, Connect, and Quit Mobile Application
|
150 |
All |
18 Years and older (Adult, Older Adult) |
NCT03978455 |
2019-0274
R35CA197573 |
|
June 18, 2019 |
June 2020 |
June 2020 |
June 7, 2019 |
June 25, 2019 |
|
- University of Wisconsin Center for Tobacco Research and Intervention
Madison, Wisconsin, United States
|
|
| 44 |
NCT03976414 |
Recruiting |
Mind Over Matter: Electronic Bladder and Bowel Continence Self-management Program |
- Incontinence, Urinary
- Incontinence Bowel
|
|
Observational
|
|
- University of Wisconsin, Madison
|
Other |
- Observational Model: Ecologic or Community
- Time Perspective: Prospective
|
- Response on global perception of improvement (GPI) tool at 4 months
- Change in the response of Global patient satisfaction question (PSQ)
- Change in patient estimated percent improvement (EPI)
- (and 9 more...)
|
800 |
Female |
18 Years to 100 Years (Adult, Older Adult) |
NCT03976414 |
2018-1147 |
|
June 1, 2019 |
November 1, 2019 |
May 31, 2020 |
June 6, 2019 |
June 18, 2019 |
|
- University of Wisconsin-Madison School of Medicine and Public Health
Madison, Wisconsin, United States
|
|
| 45 |
NCT03972930 |
Recruiting |
Stereotactic Body Radiotherapy for Soft Tissue Sarcomas |
|
- Radiation: Stereotactic Body Radiotherapy
|
Interventional
|
Phase 2 |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Proportion of Participants with 2-year Local Control
- Proportion of Participants with 2-year Local Control: Primary Site vs Metastatic Site
- Proportion of Participants with 5-year Local Control: Primary Site vs Metastatic Site
- (and 5 more...)
|
48 |
All |
18 Years and older (Adult, Older Adult) |
NCT03972930 |
UW18149
2019-0360 |
|
June 11, 2019 |
July 1, 2023 |
July 1, 2026 |
June 4, 2019 |
July 29, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 46 |
NCT03971591 |
Recruiting |
Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors |
|
- Behavioral: Guided Lifestyle Program Intervention
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
- Loyola University Chicago
- Marquette University
- University of Illinois at Chicago
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Change in body composition
- Increase in intake of fruits and vegetables
- Decrease of intake of red meat/processed meat
- (and 25 more...)
|
200 |
Male |
18 Years and older (Adult, Older Adult) |
NCT03971591 |
PRO00031416 |
MMF |
June 1, 2019 |
June 30, 2022 |
June 30, 2023 |
June 3, 2019 |
August 13, 2019 |
|
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 47 |
NCT03960502 |
Completed |
A Safety and Pharmacokinetic Study of AG-881 in Healthy Male Participants Following Administration of a Single Oral Dose of [14C] AG-881 and Concomitant Intravenous Microdose of [13C315N3] AG-881 |
- Healthy Male Participants
|
- Drug: AG-881
- Drug: [13C315N3]AG-881
|
Interventional
|
Phase 1 |
- Agios Pharmaceuticals, Inc.
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- Amount of AG-881 Excreted in Urine (Aeu)
- Cumulative Aeu (Cum Aeu) of AG-881
- Percentage of AG-881 excreted in Urine and Feces (feu and fef, Respectively)
- (and 26 more...)
|
25 |
Male |
18 Years to 55 Years (Adult) |
NCT03960502 |
AG881-C-005 |
|
May 16, 2019 |
September 7, 2019 |
September 7, 2019 |
May 23, 2019 |
September 26, 2019 |
|
- Covance Clinical Research Unit Inc.
Madison, Wisconsin, United States
|
|
| 48 |
NCT03959163 |
Recruiting |
The Validity of the Quick Renal MRI in Pediatric Kidney Disease |
- Pyelonephritis
- Pyelonephritis Acute
- Renal Sclerosis
|
- Diagnostic Test: Quick MRI
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Diagnostic
|
- Sensitivity of Quick MRI as Compared to DMSA scan in Diagnosis of Suspected Acute Pyelonephritis
- Sensitivity of Quick MRI as compared to DMSA scan in Diagnosis of Renal Scars
- Specificity of Quick MRI as compared to DMSA scan in Diagnosis of Renal Scars
|
100 |
All |
up to 21 Years (Child, Adult) |
NCT03959163 |
2018-0492 |
|
May 7, 2019 |
May 2023 |
May 2023 |
May 22, 2019 |
May 22, 2019 |
|
- American Family Children's Hospital
Madison, Wisconsin, United States
|
|
| 49 |
NCT03958383 |
Recruiting |
IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for Melanoma |
|
- Biological: hu14.18-IL2
- Radiation: Radiation Therapy
- Biological: Nivolumab
- Biological: Ipilimumab
|
Interventional
|
Phase 1
Phase 2 |
- University of Wisconsin, Madison
- National Cancer Institute (NCI)
- Bristol-Myers Squibb
- (and 2 more...)
|
Other / NIH / Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Incidence of Adverse Events
- Maximum Tolerated Dose (MTD)
- Maximum Administered Dose (MAD)
- (and 19 more...)
|
61 |
All |
18 Years and older (Adult, Older Adult) |
NCT03958383 |
UW16134
P30CA014520
2017-1464
R35CA197078
A536755
SMPH/PEDIATRICS/PEDIATRICS |
|
November 2019 |
August 15, 2024 |
August 15, 2025 |
May 22, 2019 |
October 4, 2019 |
|
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
|
|
| 50 |
NCT03958214 |
Recruiting |
Promoting Self-Regulation Skills and Healthy Eating Habits in Early Head Start |
|
- Behavioral: Recipe 4 Success
- Behavioral: Usual practice Early Head Start
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
- Penn State University
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Prevention
|
- Change in children's healthy eating habits: Body mass index
- Change in children's healthy eating habits: Food diaries
- Change in children's healthy eating habits: Parent reports
- (and 6 more...)
|
240 |
All |
2 Years to 3 Years (Child) |
NCT03958214 |
2016-0465 |
|
November 8, 2015 |
December 31, 2019 |
December 31, 2019 |
May 21, 2019 |
May 21, 2019 |
|
- University of Wisconsin-Madison
Madison, Wisconsin, United States
|
|
| 51 |
NCT03958123 |
Completed |
Evaluation of the Effects of Multiple Doses of Cebranopadol on the Electrical Activity of the Heart in Healthy Subjects |
- Prolonged QTc Interval
- Pharmacokinetic
|
- Drug: 100 μg cebranopadol
- Drug: 200 μg cebranopadol
- Drug: 400 μg cebranopadol
- (and 3 more...)
|
Interventional
|
Phase 1 |
- Grünenthal GmbH
- Forest Laboratories
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- QTcNi change from time-matched baseline measurement on Day -1 to Day 29 - supported sitting position
- QTcNi change from time-matched baseline measurement on Day -1 to Day 29 - supine position
- QTcF change from time-matched baseline measurement on Day -1 to Day 29 - sitting position
- (and 38 more...)
|
171 |
All |
18 Years to 45 Years (Adult) |
NCT03958123 |
GRT-PK-12 |
|
July 10, 2013 |
November 27, 2013 |
November 27, 2013 |
May 21, 2019 |
May 23, 2019 |
|
- US001 Contract research organization
West Bend, Wisconsin, United States
|
|
| 52 |
NCT03950414 |
Recruiting |
A Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Kidney Transplant Recipients |
- Cytomegalovirus Infections
- Kidney Transplant Infection
|
- Biological: CMV specific T-cells
|
Interventional
|
Phase 1 |
- University of Wisconsin, Madison
- University of Wisconsin Program for Advanced Cell Therapy (PACT)
- University of Wisconsin School of Medicine and Public Health (UWSMPH)
- UW Health
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Safety and Tolerability:Time of Occurence of Acute GVHD
- Safety and Tolerability: Number of infusion-related adverse events
- Incidence of acute infusion-related toxicity
- (and 14 more...)
|
20 |
All |
18 Years to 75 Years (Adult, Older Adult) |
NCT03950414 |
2019-0060
PACT VST-C-002 |
|
September 27, 2019 |
August 2023 |
August 2023 |
May 15, 2019 |
October 4, 2019 |
|
- University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin, United States
|
|
| 53 |
NCT03949140 |
Recruiting |
Laser Hair Removal for Treatment of Pilonidal Disease |
|
- Procedure: Laser hair removal
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Incidence of disease-free remission
- Disease recurrence rate among subjects who subsequently require surgical intervention.
- Characterization of the degree of intervention required to obtain positive results.
- (and 4 more...)
|
20 |
All |
13 Years to 35 Years (Child, Adult) |
NCT03949140 |
2018-1031 |
|
February 18, 2019 |
February 2020 |
September 2021 |
May 14, 2019 |
May 14, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 54 |
NCT03943901 |
Not yet recruiting |
Split-Dose R-CHOP for Older Adults With DLBCL |
- Diffuse Large B Cell Lymphoma
- DLBCL
- Cancer
|
- Drug: Rituximab
- Drug: Cyclophosphamide
- Drug: Doxorubicin
- (and 3 more...)
|
Interventional
|
Phase 2 |
- University of Wisconsin, Madison
- Medical College of Wisconsin
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Complete Response Rate (CR)
- Progression Free Survival (PFS)
- Overall Survival (OS)
- (and 2 more...)
|
46 |
All |
70 Years and older (Older Adult) |
NCT03943901 |
UW18131
2019-0138
SMPHMEDICINEHEM-ONC
A534260 |
|
October 20, 2019 |
August 20, 2021 |
August 20, 2022 |
May 9, 2019 |
September 23, 2019 |
|
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
|
|
| 55 |
NCT03940157 |
Recruiting |
Faith and Community in Action: Increasing Awareness and Management of Depression in African American Communities |
- Depression
- Awareness
- Self-management
|
- Behavioral: Oh Happy Day Class - Still I Rise
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
- Urban League of Greater Madison
- African American Council of Churches Madison
- (and 2 more...)
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Patient Health Questionnaire-9 (PhQ-9)
|
100 |
All |
25 Years to 75 Years (Adult, Older Adult) |
NCT03940157 |
2019-0129 |
|
July 1, 2019 |
December 31, 2019 |
June 30, 2020 |
May 7, 2019 |
July 15, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 56 |
NCT03939702 |
Completed |
Pharmacokinetic and Metabolism of [14^C] BMS-986177 in Healthy Male Participants |
|
|
Interventional
|
Phase 1 |
|
Industry |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Health Services Research
|
- Assess PK Cmax of a dose of [14C]BMS-986177
- Assess PK AUC(INF) of a dose of [14C]BMS-986177
- Assess PK AUC(0-T) of a dose of [14C]BMS-986177
- (and 19 more...)
|
9 |
Male |
18 Years to 50 Years (Adult) |
NCT03939702 |
CV010-036 |
|
May 2, 2019 |
July 11, 2019 |
July 11, 2019 |
May 7, 2019 |
October 4, 2019 |
|
- Covance Clinical Research Unit, Inc.
Madison, Wisconsin, United States
|
|
| 57 |
NCT03936478 |
Suspended |
Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer |
|
- Radiation: MRIdian Radiation Treatment Unit
|
Interventional
|
Phase 2 |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Physician Reported Cosmesis: 1-year
- Participant Quality of Life: BCTOS Survey
- Participant Quality of Life: Convenience of Care Scale
- (and 9 more...)
|
30 |
Female |
40 Years and older (Adult, Older Adult) |
NCT03936478 |
UW18099
2019-0322
SMPHHUMAN ONCOHUMAN ONCO
A533300 |
MAPBI |
November 2019 |
July 1, 2022 |
July 1, 2026 |
May 3, 2019 |
October 4, 2019 |
|
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
|
|
| 58 |
NCT03935880 |
Recruiting |
Surgical Treatment for Great Toe Arthritis |
|
- Device: Cartiva Implant
- Procedure: Cheilectomy
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change in foot and ankle ability : Assessment by Foot and Ankle Ability Measure (FAAM) Questionnaire
- Change in patient health : Assessment by 36-Item Short Form Survey (SF-36) Questionnaire
|
120 |
All |
18 Years to 88 Years (Adult, Older Adult) |
NCT03935880 |
2018-1546 |
|
April 15, 2019 |
April 2022 |
April 2022 |
May 2, 2019 |
May 2, 2019 |
|
- UW Health
Madison, Wisconsin, United States
|
|
| 59 |
NCT03935516 |
Enrolling by invitation |
Extended vs Flexed Elbow Casting |
|
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Alignment
- Complication Rate
- Range of Motion
- Caregiver Satisfaction Scores
|
176 |
All |
up to 18 Years (Child, Adult) |
NCT03935516 |
2017-1056
SMPHORTHOPEDIC&REHABORTHO
A536110 |
|
December 19, 2017 |
June 30, 2020 |
June 30, 2020 |
May 2, 2019 |
May 2, 2019 |
|
- American Family Children's Hospital
Madison, Wisconsin, United States
|
|
| 60 |
NCT03933813 |
Recruiting |
Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients |
- Epithelial Ovarian Cancer
- Anemia
- Iron Deficiency Anemia
|
|
Interventional
|
Phase 1
Phase 2 |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Rate of Peri-operative Blood Transfusion
- Rate of Iron Deficiency Anemia
- Rate of Resolution of Iron Deficiency Anemia After Intervention
- Incidence of Treatment Emergent Adverse Events (AEs)
|
40 |
Female |
18 Years and older (Adult, Older Adult) |
NCT03933813 |
UW18106
2019-0022
A532820
SMPH/OBSTET & GYNECOL/OBSTET |
|
July 29, 2019 |
January 2020 |
January 2020 |
May 1, 2019 |
October 1, 2019 |
|
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
|
|
| 61 |
NCT03931590 |
Recruiting |
A Human AME Study for Omaveloxolone |
|
- Drug: [14C]-Omaveloxolone
|
Interventional
|
Phase 1 |
- Reata Pharmaceuticals, Inc.
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Maximum concentration (Cmax) of omaveloxolone
- Area under the omaveloxolone concentration-time curve (AUC)
- Maximum concentration of total radioactivity in blood and plasma
- (and 3 more...)
|
8 |
Male |
18 Years to 55 Years (Adult) |
NCT03931590 |
408-C-1805 |
|
April 11, 2019 |
December 2019 |
December 2019 |
April 30, 2019 |
April 30, 2019 |
|
- Covance Clinical Research Unit (CRU) Inc.
Madison, Wisconsin, United States
|
|
| 62 |
NCT03931330 |
Recruiting |
Does Improving Vagal Tone Increase Mitochondrial Bioenergetics |
- Functional Gastrointestinal Disorders
- Irritable Bowel Syndrome
- Dyspepsia
- Functional Abdominal Pain Syndrome
|
- Device: Percutaneous neurostimulation
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Mitochondrial Bioenergetics
- Heart Rate Variability
- Functional Disability Inventory
|
7 |
All |
12 Years to 18 Years (Child, Adult) |
NCT03931330 |
1101710 |
|
October 10, 2017 |
September 2019 |
September 2020 |
April 30, 2019 |
April 30, 2019 |
|
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 63 |
NCT03922139 |
Recruiting |
Botox for the Treatment of Chronic Exertional Compartment Syndrome |
- Compartment Syndrome of Leg
|
- Drug: OnabotulinumtoxinA Injection
|
Interventional
|
Phase 1
Phase 2 |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Decrease in pain as assessed by change in Sliding pain scale
|
12 |
All |
18 Years and older (Adult, Older Adult) |
NCT03922139 |
2017-1061
Ortho Rehab |
|
October 2019 |
March 2021 |
March 2021 |
April 19, 2019 |
September 11, 2019 |
|
- Pain Management Clinic
Madison, Wisconsin, United States
|
|
| 64 |
NCT03921255 |
Recruiting |
Cognitive Bias Modification for Thought-Action Fusion |
- Obsessive-Compulsive Disorder
|
- Other: Cognitive Bias Modification
|
Interventional
|
Not Applicable |
- University of Wisconsin, Milwaukee
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in Thought-Action Fusion Scale (TAFS) across Pre-training, Post-training, and 1-Month follow-up
- Change in Primary Obsession Evaluation of TAF Scale (POETS) across Pre-training, Post-training, and 1-Month follow-up
- Change in Revised Obsessional Intrusions Inventory - Distress (ROII-Distress) across Pre-training, Post-training, and 1-Month follow-up
|
66 |
All |
18 Years and older (Adult, Older Adult) |
NCT03921255 |
TAF Extended |
TAF |
April 10, 2016 |
August 31, 2019 |
August 31, 2019 |
April 19, 2019 |
April 19, 2019 |
|
- UWM Anxiety Disorders Laboratory
Milwaukee, Wisconsin, United States
|
|
| 65 |
NCT03919669 |
Enrolling by invitation |
A Longitudinal Evaluation of a Radiotracer for Use in Tau Tracking |
- Alzheimer Disease
- Mild Cognitive Impairment
|
|
Interventional
|
Phase 2 |
- University of Wisconsin, Madison
- Cerveau Technologies, Inc.
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Diagnostic
|
- Change in [18F]MK-6240 uptake
- Correlate the changes in [18F]MK-6240 uptake and changes in clinical cognitive assessments by Mini-Mental Status Exam (MMSE)
- Correlate the changes in [18F]MK-6240 uptake and changes in clinical cognitive assessments by Clinical Dementia Rating Scale (CDR).
- (and 2 more...)
|
42 |
All |
50 Years to 85 Years (Adult, Older Adult) |
NCT03919669 |
2018-1348 |
|
April 1, 2019 |
January 2022 |
September 2022 |
April 18, 2019 |
May 24, 2019 |
|
- University of Wisconsin-Madison
Madison, Wisconsin, United States
|
|
| 66 |
NCT03913468 |
Active, not recruiting |
Outcomes of Septic Shock Patients Treated With a Metabolic Resuscitation Bundle Consisting of Intravenous Hydrocortisone, Ascorbic Acid and Thiamine. |
- Septic Shock
- Ascorbic Acid Deficiency
|
- Drug: Intravenous Ascorbic Acid
|
Observational
|
|
- University of Wisconsin, Madison
|
Other |
- Observational Model: Cohort
- Time Perspective: Retrospective
|
- Duration of Vasopressors
- ICU mortality
- Need for Renal Replacement Therapy
|
80 |
All |
18 Years to 90 Years (Adult, Older Adult) |
NCT03913468 |
2018-1310 |
|
January 1, 2019 |
April 1, 2020 |
April 1, 2020 |
April 12, 2019 |
October 4, 2019 |
|
- University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
|
|
| 67 |
NCT03911609 |
Recruiting |
Cardiovascular Autonomic Function and Endogenous Pain Modulation |
- Fibromyalgia
- Exercise
- Pain
- (and 2 more...)
|
- Other: Exercise
- Other: Cognitive Task
|
Interventional
|
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Change from Baseline Pressure Pain Threshold to immediately after performance of exercise.
- Change from Baseline Pressure Pain Threshold to immediately after cognitive task.
- Change from Baseline Pressure Pain Threshold to during the submersion of the foot in ice water.
- (and 18 more...)
|
250 |
All |
18 Years to 75 Years (Adult, Older Adult) |
NCT03911609 |
HR-1812027243 |
|
March 20, 2019 |
December 30, 2022 |
December 30, 2022 |
April 11, 2019 |
April 11, 2019 |
|
- Marquette University
Milwaukee, Wisconsin, United States
|
|
| 68 |
NCT03900416 |
Recruiting |
Adolescent Mindfulness Mobile App Study (RCT) |
- Rumination
- Depression
- Anxiety
- Self-Injurious Behavior
|
- Behavioral: Mindfulness App
|
Interventional
|
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Children's Response Styles Questionnaire
- Children's Depression Inventory
- Multidimensional Anxiety Scale for Children
- (and 14 more...)
|
150 |
All |
12 Years to 15 Years (Child) |
NCT03900416 |
7_25_18_Hilt |
AMMASRCT |
June 17, 2019 |
May 1, 2021 |
October 1, 2021 |
April 3, 2019 |
August 27, 2019 |
|
- Lawrence University
Appleton, Wisconsin, United States
|
|
| 69 |
NCT03896620 |
Recruiting |
Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma |
|
- Diagnostic Test: Blood Test - Stage 2-3 Sarcomas Preoperative RT
- Diagnostic Test: Blood Test - Stage 2-3 Sarcomas Postoperative RT
- Diagnostic Test: Blood Test - Stage 4 Sarcomas
- Diagnostic Test: Biopsy Sample of Tumor
|
Observational
|
|
- Medical College of Wisconsin
|
Other |
- Observational Model: Other
- Time Perspective: Other
|
- The proportion of patients with detectable ctDNA changes from pretreatment to posttreatment.
- The correlation of ctDNA presence with overall survival.
- The correlation of ctDNA presence with progression-free survival.
|
50 |
All |
18 Years and older (Adult, Older Adult) |
NCT03896620 |
PRO00034441 |
|
June 18, 2019 |
May 1, 2023 |
May 1, 2024 |
April 1, 2019 |
July 3, 2019 |
|
- Froedtert Hospital & the Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 70 |
NCT03891797 |
Active, not recruiting |
PTSD Treatment for Incarcerated Men and Women |
|
- Other: Cognitive Processing Therapy
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- PTSD-Checklist-5 (PCL-5)
- Eligibility
- Participation
- (and 8 more...)
|
53 |
All |
18 Years to 55 Years (Adult) |
NCT03891797 |
2018-0630
A538900
SMPH/PSYCHIATRY/PSYCHIATRY |
|
March 5, 2019 |
October 14, 2019 |
December 25, 2019 |
March 27, 2019 |
October 1, 2019 |
|
- Fox Lake Correctional Institute
Fox Lake, Wisconsin, United States
|
|
| 71 |
NCT03889522 |
Recruiting |
The Influence of Non-Caloric Artificial Sweeteners on Youth With Type 1 Diabetes |
|
- Diagnostic Test: Bioelectrical Impedance Analysis
- Diagnostic Test: Total Body Dual-energy X-ray Absorptiometry
- Diagnostic Test: Blood draw
|
Observational
|
|
- Medical College of Wisconsin
|
Other |
- Observational Model: Cohort
- Time Perspective: Cross-Sectional
|
- Quantify artificial sweetener consumption in youth with type 1 diabetes
- Examine the relationship between artificial sweeteners and body composition
- Examine the relationship between artificial sweeteners and kidney function
- (and 5 more...)
|
30 |
All |
5 Years to 17 Years (Child) |
NCT03889522 |
1351723 |
|
May 1, 2019 |
May 1, 2020 |
May 1, 2020 |
March 26, 2019 |
June 7, 2019 |
|
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 72 |
NCT03888040 |
Enrolling by invitation |
Fatigability of Lower Limb Muscle in Older Adults: Protective Effects of Strength Training Exercise in Old Men and Women |
|
|
Interventional
|
Not Applicable |
- Marquette University
- National Institute on Aging (NIA)
- Ball State University
- Medical College of Wisconsin
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Changes in 1 RM (One Repetition Maximum) after 8 weeks resistance training
- Changes in Maximum voluntary contraction (MVC) force after 8 weeks resistance training
- Changes in Knee Extensor Power Curve after 8 weeks resistance training
- (and 17 more...)
|
182 |
All |
18 Years and older (Adult, Older Adult) |
NCT03888040 |
HR-2945
R01AG048262 |
|
April 22, 2015 |
December 31, 2021 |
December 31, 2021 |
March 25, 2019 |
March 25, 2019 |
|
- Sandra K. Hunter
Milwaukee, Wisconsin, United States
|
|
| 73 |
NCT03887572 |
Recruiting |
Adaption of Mobilizing Older Adult Patients Via a Systems-based Intervention for a Non-Academic Hospital |
- Early Mobility
- Older Adults
- Hospital Acquired Condition
|
|
Observational
|
|
- University of Wisconsin, Madison
- University of Wisconsin Institute for Clinical and Translational Research
- Aurora Health Care
|
Other |
- Observational Model: Case-Control
- Time Perspective: Prospective
|
- Change in gait speed
- Change in Self-report on Katz Activity of Daily Living (ADL) Index
- Change in Life Space Assessment
- (and 16 more...)
|
40 |
All |
65 Years and older (Older Adult) |
NCT03887572 |
2018-1025 |
MOVIN |
March 4, 2019 |
December 31, 2019 |
March 31, 2020 |
March 25, 2019 |
March 25, 2019 |
|
- Aurora St. Luke's Medical Center
Milwaukee, Wisconsin, United States
|
|
| 74 |
NCT03881397 |
Recruiting |
Youth Health and Social Media |
- Sleep
- Physical Activity
- Family and Household
- (and 2 more...)
|
- Behavioral: Family Media Use Plan
- Behavioral: Media Use Resources Awareness
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
- Facebook, Inc.
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Technology and Media Use Rules
- Changes in sleep behavior
- Changes in risk for Problematic Internet Use
|
3000 |
All |
12 Years to 17 Years (Child) |
NCT03881397 |
2018-0787 |
|
April 4, 2019 |
December 2019 |
December 2020 |
March 19, 2019 |
April 29, 2019 |
|
- University of Wisconsin Madison
Madison, Wisconsin, United States
|
|
| 75 |
NCT03873129 |
Recruiting |
ART-CHESS: A Mobile Health Application to Support People Living With HIV and Addiction |
- HIV/AIDS
- Substance Use Disorders
|
- Behavioral: mobile health app (mHealth)
|
Interventional
|
Phase 2 |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Change in the Viral suppression among study semesters of A-CHESS use versus semesters of without A-CHESS use.
- Change in the Attendance at HIV Clinic Appointments among study semesters of A-CHESS use versus semesters of without A-CHESS use.
- Change in the Drug usage among study semesters of A-CHESS use versus semesters of without A-CHESS use.
- Change in the Medication adherence among study semesters of A-CHESS use versus semesters of without A-CHESS use.
|
360 |
All |
18 Years and older (Adult, Older Adult) |
NCT03873129 |
2016-1190 |
|
May 2016 |
March 2021 |
March 2021 |
March 13, 2019 |
March 13, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 76 |
NCT03871504 |
Recruiting |
The Influence of Baseline Sensitivity and Expectation on Exercise-induced Hypoalgesia in Young Healthy Adults |
|
- Other: Submaximal isometric exercise
|
Interventional
|
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- The change from baseline of pain ratings during temporal summation of pressure pain assessment
- Expectation
- State version of the State-Trait Anxiety Inventory (STAI)
- (and 6 more...)
|
250 |
All |
18 Years and older (Adult, Older Adult) |
NCT03871504 |
HR-2999 |
|
November 25, 2017 |
December 30, 2022 |
December 30, 2022 |
March 12, 2019 |
March 12, 2019 |
|
- Marquette University
Milwaukee, Wisconsin, United States
|
|
| 77 |
NCT03864926 |
Recruiting |
Envarsus in Delayed Graft Function (E-DGF) |
|
- Drug: Envarsus XR
- Drug: Tacrolimus
|
Interventional
|
Phase 4 |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Number of days needed to recover from delayed graft function (DGF)
- Number of Tacrolimus or Envarsus XR Dose Adjustments Required During the Period of DGF.
|
100 |
All |
18 Years and older (Adult, Older Adult) |
NCT03864926 |
2018-0530 |
E-DGF |
March 18, 2019 |
February 2021 |
August 2021 |
March 6, 2019 |
April 4, 2019 |
|
- University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
|
|
| 78 |
NCT03864601 |
Completed |
A Study of (14C) Radiolabeled JNJ-56136379 in Healthy Male Participants |
|
|
Interventional
|
Phase 1 |
- Janssen Research & Development, LLC
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- Cmax: Ratio of JNJ-56136379 Concentration and Total Radioactivity in Plasma
- AUC(0-last): Ratio of JNJ-56136379 Concentration and Total Radioactivity in Plasma
- AUC(0-infinity): Ratio of JNJ-56136379 Concentration and Total Radioactivity in Plasma
- (and 17 more...)
|
6 |
Male |
18 Years to 55 Years (Adult) |
NCT03864601 |
CR108586
56136379HPB1007 |
|
April 9, 2019 |
June 14, 2019 |
June 14, 2019 |
March 6, 2019 |
August 7, 2019 |
|
- Covance Clinical Research Unit
Madison, Wisconsin, United States
|
|
| 79 |
NCT03863509 |
Recruiting |
E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease |
- Tobacco Use
- E-Cigarette Use
- Cardiovascular Diseases
- Pulmonary Disease
|
- Behavioral: Cigarettes
- Behavioral: E-Cigarettes
|
Observational
|
|
- University of Wisconsin, Madison
- National Institutes of Health (NIH)
- National Heart, Lung, and Blood Institute (NHLBI)
- University of Wisconsin Center for Tobacco Research and Intervention
|
Other / NIH |
- Observational Model: Case-Control
- Time Perspective: Prospective
|
- Brachial Artery Flow-Mediated Dilation (FMD)
- Forced Expiratory Volume (FEV1)
- Carotid Intima-Media Thickness (IMT)
- (and 9 more...)
|
440 |
All |
18 Years and older (Adult, Older Adult) |
NCT03863509 |
2017-1090
1R01HL139331-01 |
|
March 5, 2019 |
April 30, 2022 |
December 30, 2022 |
March 5, 2019 |
March 28, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 80 |
NCT03856320 |
Recruiting |
Teaching Obesity Treatment Options to Adult Learners Trial |
- Obesity
- Patient Education
- Weight Loss
|
- Behavioral: Educational Video
|
Interventional
|
Not Applicable |
- VA Office of Research and Development
- The Clowes Fund, Inc.
|
U.S. Fed / Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Health Services Research
|
|
40 |
All |
18 Years to 70 Years (Adult, Older Adult) |
NCT03856320 |
CDX 18-001 |
TOTAL |
May 13, 2019 |
May 13, 2020 |
June 30, 2023 |
February 27, 2019 |
May 15, 2019 |
|
- William S. Middleton Memorial Veterans Hospital, Madison, WI
Madison, Wisconsin, United States
|
|
| 81 |
NCT03853811 |
Recruiting |
Customized Orthosis for Children With Clubfoot |
- Congenital Talipes Equinovarus
|
- Device: Ankle Foot Orthosis (AFO)
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Assessment of Functional Outcomes of Bracing Treatment Using Dimeglio Scores
- Time Spent in Brace to Assess Brace Compliance
- Assessing Treatment Factors that Impact Brace Compliance with Parental Questionnaires
- Assessing Demographic Factors that Impact Brace Compliance with Parental Questionnaire
|
10 |
All |
up to 12 Months (Child) |
NCT03853811 |
1246407 |
|
April 17, 2019 |
March 1, 2020 |
March 1, 2020 |
February 26, 2019 |
April 30, 2019 |
|
- Children's Hospital of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 82 |
NCT03853473 |
Recruiting |
Prehabilitation of Frail Surgical Cancer Patients Using Remote Ischemic Preconditioning |
- Colon Cancer
- Fragility
- Prehabilitaiton
- Surgery
|
- Procedure: Remote Ischemic Preconditioning
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- 6 Minute Walk Test Distance (Pre Surgery)
- 10 Meter Walk Test (Pre Surgery)
- Timed Up and Go (Pre Surgery)
- (and 6 more...)
|
96 |
All |
55 Years to 85 Years (Adult, Older Adult) |
NCT03853473 |
PRO00032510 |
Prehab |
February 22, 2019 |
February 21, 2022 |
February 21, 2022 |
February 25, 2019 |
February 25, 2019 |
|
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 83 |
NCT03848754 |
Recruiting |
Pracinostat in Combination With Gemtuzumab Ozogamicin (PraGO) in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) |
|
- Drug: Gemtuzumab Ozogamicin
- Drug: Pracinostat
|
Interventional
|
Phase 1 |
- Medical College of Wisconsin
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Maximum-tolerated dose
- Overall Response
- Progression-Free Survival
- Overall Survival
|
18 |
All |
18 Years and older (Adult, Older Adult) |
NCT03848754 |
PRO 33922 |
|
May 24, 2019 |
May 2020 |
March 2021 |
February 21, 2019 |
June 10, 2019 |
|
- Froedtert Hospital & the Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 84 |
NCT03848689 |
Enrolling by invitation |
FQ Restriction for the Prevention of CDI |
- Clostridium Difficile
- Clostridium Difficile Infection
- C Difficile Colitis
|
- Other: fluoroquinolone preprescription authorization
- Other: Control
|
Observational
|
|
- University of Wisconsin, Madison
- Agency for Healthcare Research and Quality (AHRQ)
|
Other / U.S. Fed |
- Observational Model: Other
- Time Perspective: Prospective
|
- Change in the number of Incidences of hospital-onset due to Clostridium difficile infection (CDI) before and after following FQ PPA strategy
- Change in the number of Incidences of healthcare-associated CDI before and after following FQ PPA strategy
- Change in the usage of FQ from the time of participant hospital admission per 1000 patient-days.
- (and 6 more...)
|
11000 |
All |
Child, Adult, Older Adult |
NCT03848689 |
2018-0852
1R01HS026226-01 |
FIRST |
January 1, 2018 |
February 28, 2023 |
June 30, 2023 |
February 21, 2019 |
February 21, 2019 |
|
- University of Wisconsin Hospital & Clinics
Madison, Wisconsin, United States
|
|
| 85 |
NCT03837392 |
Recruiting |
Efficacy of Brief Acceptance and Commitment Therapy (ACT) for Perinatal Depression |
- Post Partum Depression
- Perinatal Depression
- Post Partum Anxiety
- Perinatal Anxiety
|
- Diagnostic Test: Initial Screening at Enrollment (14-20 weeks pregnant)
- Diagnostic Test: Pregnancy Planning Visit
- Behavioral: Group Intervention: ACT Session
- (and 3 more...)
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Health Services Research
|
- Change in Hamilton Depression and Rating Scale (HDRS) from Baseline
- Change in Hamilton Anxiety Rating Scale (HAM-A) from Baseline
- Change in Five Facet Mindfulness Questionnaire (FFMQ) from Baseline
- (and 16 more...)
|
80 |
Female |
18 Years to 45 Years (Adult) |
NCT03837392 |
2018-1165 |
|
February 18, 2019 |
February 15, 2021 |
February 15, 2021 |
February 12, 2019 |
February 19, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 86 |
NCT03827447 |
Recruiting |
Vancomycin for the Treatment of NAAT(+)/Toxin(-) C. Difficile |
- Clostridium Difficile Infection
|
- Drug: Vancomycin Oral Capsule
- Drug: Placebo Oral Capsule
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Investigator)
- Primary Purpose: Treatment
|
- Determine the change in C. difficile loads between the vancomycin vs. placebo group.
- Determine the long-term persistence of C. difficile from the change in qPCR levels between the vancomycin vs. placebo group
- Characterize the change on structural alterations of the microbiome after end of treatment between the vancomycin vs. placebo groups through 16S rRNA sequencing.
- (and 5 more...)
|
30 |
All |
18 Years and older (Adult, Older Adult) |
NCT03827447 |
PRO00033844 |
|
July 17, 2019 |
June 1, 2021 |
June 1, 2022 |
February 1, 2019 |
October 4, 2019 |
|
- Medical College of Wisconsin, Inc.
Milwaukee, Wisconsin, United States
|
|
| 87 |
NCT03824145 |
Active, not recruiting |
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer |
|
- Behavioral: Lifestyle Intervention
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
- Loyola University Chicago
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Intervention adherence
- Intervention retention
- Change in Quality of Life
- (and 9 more...)
|
40 |
Female |
18 Years and older (Adult, Older Adult) |
NCT03824145 |
27600 |
EDC |
January 2, 2018 |
June 30, 2019 |
June 30, 2021 |
January 31, 2019 |
August 13, 2019 |
|
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 88 |
NCT03818295 |
Completed |
A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Praliciguat in Healthy Male Volunteers |
|
|
Interventional
|
Phase 1 |
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Other
|
- Amount of total radioactivity excreted in urine (Aeu) and feces (Aef)
- Cumulative Aeu and cumulative Aef
- Percentage of total radioactivity excreted in urine (feu) and feces (fef)
- (and 27 more...)
|
8 |
Male |
18 Years to 55 Years (Adult) |
NCT03818295 |
PRL-105 |
|
March 1, 2019 |
April 24, 2019 |
April 24, 2019 |
January 28, 2019 |
June 19, 2019 |
|
- Covance Clinical Research Unit Inc.
Madison, Wisconsin, United States
|
|
| 89 |
NCT03810235 |
Recruiting |
The OBstetric Lidocaine Patch (OBLido) Trial |
|
- Drug: Transdermal Lidocaine Patch
- Drug: Transdermal Hydrocolloid Placebo Patch
|
Interventional
|
Phase 4 |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Total dose of opioids received in the first 24 hours following Cesarean
- Post-operative pain score at 24 hours post-operatively
|
60 |
Female |
18 Years to 59 Years (Adult) |
NCT03810235 |
Meriter IRB 2018-015 |
OBLido |
February 15, 2019 |
December 31, 2019 |
March 31, 2020 |
January 18, 2019 |
February 19, 2019 |
|
- UnityPoint Health-Meriter Hospital
Madison, Wisconsin, United States
|
|
| 90 |
NCT03806283 |
Active, not recruiting |
Angiotensin 2 Receptor (AT2R) in Endothelial Cells in Preeclampsia |
- Pre-Eclampsia
- Vascular Diseases
|
- Procedure: Omental Biopsy
|
Observational
|
|
- University of Wisconsin, Madison
- National Heart, Lung, and Blood Institute (NHLBI)
|
Other / NIH |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Quantify the vascular AT2R expression and vascular function in placental and omental vascular arteries in both preeclamptic and controlled pregnancies.
- To test if ex-vivo treatment of AT2R agonists reverses the endothelial dysfunction and improves vasoconstriction in the preeclamptic vessels.
- To test AT2R mediated mechanisms on endothelial derived hyperpolarizing factor, nitric oxide and prostacyclin pathway of vascular relaxation to examine AT2's role in vaso-relaxation and AT2R mediated vasoconstrictor pathway will be defined.
|
70 |
Female |
18 Years to 35 Years (Adult) |
NCT03806283 |
Meriter IRB 2018-006
5R01HL134779-02 |
|
November 20, 2018 |
July 1, 2021 |
July 1, 2022 |
January 16, 2019 |
January 17, 2019 |
|
- UnityPoint Health-Meriter Hospital
Madison, Wisconsin, United States
|
|
| 91 |
NCT03805659 |
Not yet recruiting |
HDtDCS in Logopenic Variant PPA: Effects on Language and Neural Mechanisms |
- Primary Progressive Aphasia
|
- Device: HD-tDCS
- Device: Sham
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Language Performance on seven cognitive assessments: Picture Naming, Letter & Category Fluency, Digit Span Test, Phonological Short-term Memory Test, Word and non-word rhyme matching, Spontaneous Speech Sample, and Communicative Effectiveness Index.
- Brain Connectivity as seen on fMRI (functional MRI)
- Neuronal Frequencies and Synchronizations as seen on rsMEG (resting state MEG)
|
20 |
All |
45 Years and older (Adult, Older Adult) |
NCT03805659 |
32037 |
|
December 2019 |
May 2021 |
May 2021 |
January 16, 2019 |
October 18, 2019 |
|
- The Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 92 |
NCT03805529 |
Recruiting |
The Singing Heart Study |
- Impact of Singing
- Cardiovascular Health
- Cardiovascular Risk Factors
- Cardiovascular Diseases
|
|
Observational
|
|
- Medical College of Wisconsin
|
Other |
- Observational Model: Case-Only
- Time Perspective: Prospective
|
- The change in heart rate variability during singing
- The change from baseline vascular endothelial function in subjects who've participated in singing intervention
- The change in cardiac hemodynamics
- Asses subjects' self-assessment of perceived exertion during singing
|
70 |
All |
18 Years and older (Adult, Older Adult) |
NCT03805529 |
26191 |
|
February 22, 2018 |
August 20, 2019 |
December 1, 2019 |
January 15, 2019 |
October 4, 2019 |
|
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 93 |
NCT03801174 |
Recruiting |
Using Partners to Enhance Long-Term Weight Loss |
|
- Behavioral: Partner-assisted intervention
- Behavioral: Patient-only intervention
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
- Duke University
- RTI International
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Body weight (kg)
- Caloric intake (kcal)
- Physical activity
|
460 |
All |
18 Years to 74 Years (Adult, Older Adult) |
NCT03801174 |
2018-1400 |
Partner2Lose |
January 15, 2019 |
January 1, 2023 |
January 1, 2023 |
January 11, 2019 |
June 21, 2019 |
|
- University of Wisconsin-Madison
Madison, Wisconsin, United States
|
|
| 94 |
NCT03799120 |
Enrolling by invitation |
Daily Versus Twice Per Day Tamsulosin for Ureteral Stent Symptoms |
|
- Drug: Tamsulosin BID
- Other: Placebo
|
Interventional
|
Phase 4 |
- Gundersen Lutheran Medical Foundation
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Outcomes Assessor)
- Primary Purpose: Supportive Care
|
- Ureteric Stent Symptoms Questionnaire
|
80 |
All |
18 Years to 70 Years (Adult, Older Adult) |
NCT03799120 |
2-18-11-001 |
|
February 18, 2019 |
December 2021 |
December 2021 |
January 10, 2019 |
February 25, 2019 |
|
- Gundersen Health System
La Crosse, Wisconsin, United States
|
|
| 95 |
NCT03798691 |
Recruiting |
Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab |
- Inflammatory Bowel Diseases
- Crohn Disease
- Ulcerative Colitis
- Herpes Zoster
|
|
Interventional
|
Phase 4 |
- University of Wisconsin, Madison
- Boston Medical Center
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- Change in cell mediated immunity
- Percent of participants with sustained cell mediated immunity measured via ELISPOT after immunization.
- Percent of participants with a change in antibody concentration post immunization
- (and 3 more...)
|
30 |
All |
50 Years to 70 Years (Adult, Older Adult) |
NCT03798691 |
2018-1037
SMPH/MEDICINE/GASTROENT
A534250 |
|
May 28, 2019 |
April 1, 2020 |
January 1, 2021 |
January 10, 2019 |
June 27, 2019 |
|
- University of Wisconsin Digestive Health Center
Madison, Wisconsin, United States
|
|
| 96 |
NCT03798301 |
Recruiting |
Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells |
- CMV Infection
- Cytomegalovirus Infections
- CMV Viremia
- Opportunistic Infections
|
- Biological: CMV-specific T-cells
|
Interventional
|
Phase 1 |
- University of Wisconsin, Madison
- University of Wisconsin Program for Advanced Cell Therapy (PACT)
- University of Wisconsin Carbone Cancer Center (UWCCC)
- (and 2 more...)
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Feasibility: Number of Participants Who Drop-Out Before T-Cell Transfer
- Feasibility: Number of Days from Participant Enrollment to Administration of CMV-VST
- Feasibility: Number of Participants with Expansion of CMV-VST from Donors
- (and 9 more...)
|
20 |
All |
1 Month and older (Child, Adult, Older Adult) |
NCT03798301 |
UW18073
2018-1278
NCI-2019-00245
A536755
SMPH/PEDIATRICS/PEDIATRICS |
|
November 2019 |
September 1, 2023 |
September 1, 2024 |
January 9, 2019 |
October 4, 2019 |
|
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
|
|
| 97 |
NCT03795519 |
Completed |
A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Olinciguat in Healthy Male Volunteers |
|
|
Interventional
|
Phase 1 |
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Other
|
- Amount of total radioactivity excreted in urine (Aeu) and feces (Aef)
- Cumulative Aeu and cumulative Aef
- Percentage of total radioactivity excreted in urine (feu) and feces (fef)
- (and 27 more...)
|
8 |
Male |
18 Years to 55 Years (Adult) |
NCT03795519 |
OLI-103 |
|
January 17, 2019 |
February 27, 2019 |
February 27, 2019 |
January 7, 2019 |
April 3, 2019 |
|
- Covance Clinical Research Unit Inc.
Madison, Wisconsin, United States
|
|
| 98 |
NCT03794882 |
Recruiting |
Impact of Quadratus Lumborum Block on Recovery Profile After Ventral Hernia Repair |
- Pain, Postoperative
- Opioid Use
|
- Procedure: Quadratus Lumborum Block
- Procedure: Standard Medical Management
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Postoperative Day (POD) 1 Pain Score
- Pain Score at Rest
- Pain Score with Activity
- (and 10 more...)
|
48 |
All |
18 Years to 80 Years (Adult, Older Adult) |
NCT03794882 |
2018-0793
A530900
SMPH/ANESTHESIOLOGY/ANESTHESIO |
|
May 6, 2019 |
January 2021 |
February 2021 |
January 7, 2019 |
October 7, 2019 |
|
- University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
|
|
| 99 |
NCT03791476 |
Recruiting |
RUCONEST® as a Therapeutic Strategy to Reduce the Incidence of Delayed Graft Function |
|
- Drug: rhC1INH
- Other: Saline Solution
|
Interventional
|
Phase 1 |
- University of Wisconsin, Madison
- Pharming Technologies B.V.
|
Other / Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Investigator)
- Primary Purpose: Treatment
|
- Number of patients that do not meet DGF criteria based on creatinine levels following kidney transplantation from DCD donor who are treated with study drug compared to placebo
- Incidence of adverse and serious adverse events will be assessed via descriptive statistics method
- Ascertain whether any unexpected toxicities will occur in this patient population according to the Common Toxicity Criteria for Adverse Events (CTCAE) patient population
- (and 6 more...)
|
20 |
All |
18 Years and older (Adult, Older Adult) |
NCT03791476 |
2017-1325 |
|
June 21, 2019 |
July 2020 |
December 2020 |
January 1, 2019 |
June 25, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 100 |
NCT03787134 |
Recruiting |
Oscillatory Contributions to Working Memory and Attention |
|
- Behavioral: working memory and attention
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- Experiment 1.a. Behavioral accuracy
- Experiment 1.a. Reaction time
- Experiment 1.a. Changes in multivariate pattern classification of electroencephalography data in response to prioritization cues and in response to pulses of transcranial magnetic stimulation.
- (and 16 more...)
|
269 |
All |
18 Years to 35 Years (Adult) |
NCT03787134 |
2016-0500 |
|
March 1, 2019 |
December 2023 |
December 2023 |
December 25, 2018 |
April 24, 2019 |
|
- University of Wisconsin - Madison
Madison, Wisconsin, United States
|
|
Create an RSS feed from your search for:
Download the search results for: